Depression, Cognitive dysfunction, Alzheimer’s disease research hub

A randomised, double-blind, placebo-controlled phase Ib trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of ACD856 in healthy participants

This study is testing a new medicine, ACD856, in healthy people. We want to see if it's safe, how well the body handles it, and what it does. This research could help us learn more about treating conditions like depression or Alzheimer's disease.